Article
Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy using the LightCycler.
Journal of clinical microbiology - 1 Apr 2001
Whalley S A, Brown D, Teo C G, Dusheiko G M, Saunders N A
Abstract excerpt
Treatment of chronic hepatitis B virus (HBV) infection with lamivudine is associated with the appearance in the circulation of HBV variants with mutations in the YMDD (tyrosine, methionine, aspartate, aspartate) motif of the polymerase gene. Fluorometric real-time PCR with the LightCycler assay was used for the detection of resistant variants. Differences in the hybridization melting curve kinetics of probes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
